Consumption of medium- and long-chain triacylglycerols decreases body fat and blood triglyceride in Chinese hypertriglyceridemic subjects

European Journal of Clinical Nutrition

Volumn 63, Issue 7, 2009, Pages 879-886

  Xue, C ^a   Liu, Y ^a   Wang, J ^a   Zhang, R ^a   Zhang, Y ^a,a   Zhang, J ^a   Zheng, Z ^a   Yu, X ^a   Jing, H ^a   Nosaka, N ^b   Arai, C ^b   Kasai, M ^b   Aoyama, T ^b   Wu, J ^b,c  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b The Nisshin OilliO Group   (Japan)

^c NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; ASPARTATE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LONG CHAIN TRIACYLGLYCEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDIUM CHAIN TRIACYLGLYCEROL;

ABDOMINAL FAT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY FAT; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; INTRAABDOMINAL FAT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ABDOMINAL FAT; ADIPONECTIN; BIOLOGICAL MARKERS; BODY WEIGHT; CAPRYLATES; CHINA; DECANOATES; DIET; DIETARY FATS, UNSATURATED; DOUBLE-BLIND METHOD; FATTY ACIDS; HUMANS; HYPERTRIGLYCERIDEMIA; LEPTIN; LIPIDS; PHYSICAL EXERTION; SUBCUTANEOUS FAT; TOMOGRAPHY, X-RAY COMPUTED; TRIGLYCERIDES;

EID: 67650224313     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2008.76     Document Type: Article

References (32)

1. Alexandrou E, Herzberg GR, White MD (2007). High-level medium-chain triglyceride feeding and energy expenditure in normal-weight women. Can J Physiol Pharmacol 85, 507-513.
2. Aoyama T, Nosaka N, Kasai M (2007). Research on the nutritional characteristics of medium-chain fatty acids. J Med Invest 54 385-388.
3. Ascaso J, Gonzalez Santos P, Hernandez Mijares A, Mangas Rojas A, Masana L, Millan J et al. (2007). Management of dyslipidemia in the metabolic syndrome: Recommendations of the Spanish HDL-Forum. Am J Cardiovasc Drugs 7, 39-58.
4. Bach AC, Babayan VK (1982). Medium-chain triglycerides: An update. Am J Clin Nutr 36, 950-962.
5. Barness LA, Opitz JM, Gilbert-Barness E (2007). Obesity: Genetic, molecular, and environmental aspects. Am J Med Genet A 143, 3016-3034.
6. Betteridge DJ (2000). Diabetic dyslipidaemia. Diabetes Obes Metab 2 (Suppl 1), S31-S36.
7. Calabrese C, Myer S, Munson S, Turet P, Birdsall TC (1999). A cross-over study of the effect of a single oral feeding of medium chain triglyceride oil vs. canola oil on post-ingestion plasma triglyceride levels in healthy men. Altern Med Rev 4, 23-28.
8. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) (2001). Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486-2497.
9. Glisic S, Arrigo P, Alavantic D, Perovic V, Prljic J, Veljkovic N (2007). Lipoprotein lipase: A bioinformatics criterion for assessment of mutations as a risk factor for cardiovascular disease. Proteins 70, 855-862.
10. Hill JO, Peters JC, Swift LL, Yang D, Sharp T, Abumrad N et al. (1990). Changes in blood lipids during six days of overfeeding with medium or long chain triglycerides. J Lipid Res 31, 407-416.
11. Kasai M, Maki H, Nosaka N, Aoyama T, Ooyama K, Uto H et al. (2003a). Effect of medium-chain triglycerides on the postprandial triglyceride concentration in healthy men. Biosci Biotechnol Biochem 67, 46-53.
12. Kasai M, Nosaka N, Maki H, Negishi S, Aoyama T, Nakamura M et al. (2003b). Effect of dietary medium- and long-chain triacylglycerols (MLCT) on accumulation of body fat in healthy humans. Asia Pac J Clin Nutr 12, 151-160.
13. Kolovou GD, Anagnostopoulou KK, Cokkinos DV (2005). Pathophysiology of dyslipidaemia in the metabolic syndrome. Postgrad Med J 81, 358-366.
14. Krentz AJ (2003). Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Diabetes Obes Metab 5 (Suppl 1), S19-S27.
15. Le NA, Walter MF (2007). The role of hypertriglyceridemia in atherosclerosis. Curr Atheroscler Rep 9, 110-115.
16. Matsuo T, Takeuchi H (2004). Effects of structured medium- and long-chain triacylglycerols in diets with various levels of fat on body fat accumulation in rats. Br J Nutr 91, 219-225.
17. Matsuo T, Matsuo M, Kasai M, Takeuchi H (2001). Effects of a liquid diet supplement containing structured medium- and long-chain triacylglycerols on bodyfat accumulation in healthy young subjects. Asia Pac J Clin Nutr 10, 46-50.
18. Noguchi O, Takeuchi H, Kubota F, Tsuji H, Aoyama T (2002). Larger diet-induced thermogenesis and less body fat accumulation in rats fed medium-chain triacylglycerols than in those fed long-chain triacylglycerols. J Nutr Sci Vitaminol (Tokyo) 48, 524-529.
19. Nosaka N, Kasai M, Nakamura M, Takahashi I, Itakura M, Takeuchi H et al. (2002). Effects of dietary medium-chain triacylglycerols on serum lipoproteins and biochemical parameters in healthy men. Biosci Biotechnol Biochem 66, 1713-1718.
20. Nosaka N, Maki H, Suzuki Y, Haruna H, Ohara A, Kasai M et al. (2003). Effects of margarine containing medium-chain triacylglycerols on body fat reduction in humans. J Atheroscler Thromb 10, 290-298.
21. Ogawa A, Nosaka N, Kasai M, Aoyama T, Okazaki M, Igarashi O et al. (2007). Dietary medium- and long-chain triacylglycerols accelerate diet-induced thermogenesis in humans. J Oleo Sci 56, 283-287.
22. Roynette CE, Rudkowska I, Nakhasi DK, Jones PJ (2008). Structured medium and long chain triglycerides show short-term increases in fat oxidation, but no changes in adiposity in men. Nutr Metab Cardiovasc Dis 18, 298-305.
23. Shinohara H, Wu J, Kasai M, Aoyama T (2006). Randomly interesterified triacylglycerol containing medium- and long-chain fatty acids stimulates fatty acid metabolism in white adipose tissue of rats. Biosci Biotechnol Biochem 70, 2919-2926.
24. St-Onge MP, Jones PJ (2002). Physiological effects of medium-chain triglycerides: Potential agents in the prevention of obesity. J Nutr 132, 329-332.
25. St-Onge MP, Jones PJ (2003). Greater rise in fat oxidation with medium-chain triglyceride consumption relative to long-chain triglyceride is associated with lower initial body weight and greater loss of subcutaneous adipose tissue. Int J Obes Relat Metab Disord 27, 1565-1571.
26. St-Onge MP, Bourque C, Jones PJ, Ross R, Parsons WE (2003a). Medium- versus long-chain triglycerides for 27 days increases fat oxidation and energy expenditure without resulting in changes in body composition in overweight women. Int J Obes Relat Metab Disord 27, 95-102.
27. St-Onge MP, Ross R, Parsons WD, Jones PJ (2003b). Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men. Obes Res 11, 395-402.
28. Takeuchi H, Kasai M, Taguchi N, Tsuji H, Suzuki M (2002). Effect of triacylglycerols containing medium- and long-chain fatty acids on serum triacylglycerol levels and body fat in college athletes. J Nutr Sci Vitaminol (Tokyo) 48, 109-114.
29. Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S (1983). A novel technique for the determination of body fat by computed tomography. Int J Obes 7, 437-445.
30. Tsuji H, Kasai M, Takeuchi H, Nakamura M, Okazaki M, Kondo K (2001). Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. J Nutr 131, 2853-2859.
31. Yost TJ, Eckel RH (1989). Hypocaloric feeding in obese women: Metabolic effects of medium-chain triglyceride substitution. Am J Clin Nutr 49, 326-330.
32. Yuan G, Al-Shali KZ, Hegele RA (2007). Hypertriglyceridemia: Its etiology, effects and treatment. CMAJ 176, 1113-1120.